AMLX - DEADLINE ALERT: Bernstein Liebhard LLP Reminds Amylyx Pharmaceuticals Inc. Investors of Upcoming Deadline | Benzinga
NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:
- Do you, or did you, own securities of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX)?
- Did you purchase your securities between November 11, 2022 and November 8, 2023, inclusive?
- Did you lose money in your investment in Amylyx Pharmaceuticals, Inc.?
- Do you want to discuss your rights?
Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of Amylyx Pharmaceuticals, Inc. ("Amylyx" or the "Company") (NASDAQ:AMLX) of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.
If you purchased or acquired Amylyx securities, and/or would like to discuss your legal rights and options please visit Amylyx Pharmaceuticals, ...